No benefit from expanding cancer-risk gene test beyond the essentials
Adding more genes to existing multi-gene panels that test for breast and ovarian cancer risk offers little clinical benefit, a study says...
by Rachel Siden
Adding more genes to existing multi-gene panels that test for breast and ovarian cancer risk offers little clinical benefit, a study says...
Women with a mutation in the breast-cancer susceptibility gene BRCA1 may have reduced numbers of eggs left in their ovaries, according to a study led by Australian scientists...
by Ryan Ross
Tania Simoncelli's narrates the story of the successful legal challenge against Myriad Genetics' BRCA patents, but may have missed an opportunity to consider the broader impact of gene patenting...
Genetic-testing company Ambry Genetics has launched a huge database of cancer-patient genetics, freely available to the public...
More than 95 percent of younger women diagnosed with early-onset breast cancer are opting for genetic testing, a study has found...
US start-up company Sure Genomics has launched the first whole-genome testing service available directly to consumers, for a cost of $2500...
Scientists have identified a mutation in the gene BRIP1 that triples a woman's risk of ovarian cancer...
by Chris Hardy
Scientists have identified a link between the product of the BRCA1 gene, variants which can cause breast and ovarian cancer, and Alzheimer's disease...
A substantial proportion of childhood cancers are caused by mutations in genes that are known to cause cancer in adults, scientists have found...
An isolated gene sequence cannot be patented, Australia's highest court has unanimously ruled. It is the latest and final decision in litigation that has lasted over five years...
BioNews, published by the Progress Educational Trust (PET), provides news and comment on genetics, assisted conception, embryo/stem cell research and related areas.